Grimes & Company’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.5M | Buy |
|
|||||
|
2025
Q1 | $21.6M | Buy |
|
|||||
|
2024
Q4 | $18.2M | Buy |
|
|||||
|
2024
Q3 | $20.1M | Buy |
|
|||||
|
2024
Q2 | $17.2M | Buy |
|
|||||
|
2024
Q1 | $18.3M | Buy |
|
|||||
|
2023
Q4 | $15.4M | Buy |
|
|||||
|
2023
Q3 | $14.2M | Sell |
|
|||||
|
2023
Q2 | $12.8M | Buy |
|
|||||
|
2023
Q1 | $15.1M | Buy |
|
|||||
|
2022
Q4 | $14.8M | Buy |
|
|||||
|
2022
Q3 | $11.8M | Buy |
|
|||||
|
2022
Q2 | $13.4M | Sell |
|
|||||
|
2022
Q1 | $14.2M | Buy |
|
|||||
|
2021
Q4 | $11.8M | Buy |
|
|||||
|
2021
Q3 | $9.3M | Buy |
|
|||||
|
2021
Q2 | $9.55M | Buy |
|
|||||
|
2021
Q1 | $8.99M | Buy |
|
|||||
|
2020
Q4 | $8.18M | Buy |
|
|||||
|
2020
Q3 | $6.53M | Buy |
|
|||||
|
2020
Q2 | $7.24M | Buy |
|
|||||
|
2020
Q1 | $5.57M | Buy |
|
|||||
|
2019
Q4 | $4.04M | Buy |
|
|||||
|
2019
Q3 | $3.42M | Buy |
|
|||||
|
2019
Q2 | $3.22M | Buy |
|
|||||
|
2019
Q1 | $3.56M | Sell |
|
|||||
|
2018
Q4 | $4.08M | Sell |
|
|||||
|
2018
Q3 | $4.28M | Sell |
|
|||||
|
2018
Q2 | $4.2M | Sell |
|
|||||
|
2018
Q1 | $4.3M | Buy |
|
|||||
|
2017
Q4 | $3.08M | Buy |
|
|||||
|
2017
Q3 | $382K | Buy |
|
|||||
|
2017
Q2 | $304K | Sell |
|
|||||
|
2017
Q1 | $276K | Buy |
|
|||||
|
2016
Q4 | $253K | Buy |
|
|||||
|
2016
Q3 | $244K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $211K | Buy |
|
|||||
|
2015
Q4 | $209K | Sell |
|
|||||
|
2015
Q3 | $212K | Sell |
|
|||||
|
2015
Q2 | $265K | Buy |
|
|||||
|
2015
Q1 | $219K | Buy |
|
|||||
|
2014
Q4 | $223K | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $218K | Buy |
|